Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma.
Haneyeh ShahbazianJason BirnbaumPatricia J BurnsSedighe Hosseini ShabananDevaraju KanmanirajaJohn ReinusIhab KamelClaude B SirlinVictoria ChernyakPublished in: Abdominal radiology (New York) (2023)
The prevalence of LI-RADS v2018 categories on CT or MR exams used for HCC screening can help develop screening criteria and assess cost-effectiveness of surveillance strategies with CT and MRI.